|
WO2016112025A1
|
|
System and method for data mining very large drugs and clinical effects databases
|
|
WO2016077793A1
|
|
Sos1 inhibitors for cancer treatment
|
|
US2016120720A1
|
|
Patient support coupled medical accessory support
|
|
WO2015187496A1
|
|
Therapy for solid tumors
|
|
WO2015179779A1
|
|
Genomic instability markers in fanconi anemia
|
|
WO2015112832A1
|
|
System for transforming patient medical record data into a visual and graphical indication of patient safety risk
|
|
US2015182599A1
|
|
Surfactant protein D for the treatment of disorders associated with lung injury
|
|
WO2015077781A1
|
|
Temporal pediatric sepsis biomarker risk model
|
|
CA2921856A1
|
|
Compositions and methods for treatment of hsct-associated thrombotic microangiopathy
|
|
US2016022720A1
|
|
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
WO2015017731A1
|
|
Identification of surgery candidates using natural language processing
|
|
US2016168590A1
|
|
Methods of improving titer in transfection-based production systems using eukaryotic cells
|
|
US2015018326A1
|
|
Compositions and methods for inhibiting norovirus infection
|
|
WO2014205132A2
|
|
Methods and compositions to treat cancer
|
|
WO2014152985A1
|
|
Biomarkers of preterm necrotizing enterocolitis
|
|
US2014170107A1
|
|
Regulation of energy metabolism and obesity by modulating b cell activating factor (baff, blys) or baff signaling
|
|
US2016083353A1
|
|
Small-molecule inhibitors targeting g-protein-coupled rho guanine nucleotide exchange factors
|
|
US2014107698A1
|
|
Gastric traction device and method
|
|
WO2014036518A2
|
|
Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients
|
|
WO2013166043A1
|
|
Rejuvenation of precursor cells
|
